These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 6099868)

  • 1. Unravelling and Exploiting Astrocyte Dysfunction in Huntington's Disease.
    Khakh BS; Beaumont V; Cachope R; Munoz-Sanjuan I; Goldman SA; Grantyn R
    Trends Neurosci; 2017 Jul; 40(7):422-437. PubMed ID: 28578789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine with low-dose ketamine for cataract surgery under peribulbar block in a patient with Huntington's chorea.
    Naik S; Shetti AN; Nadkarni AV; Ahuja B
    Anesth Essays Res; 2015; 9(1):92-4. PubMed ID: 25886428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plants and phytochemicals for Huntington's disease.
    Choudhary S; Kumar P; Malik J
    Pharmacogn Rev; 2013 Jul; 7(14):81-91. PubMed ID: 24347915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington's disease: review and anesthetic case management.
    Cangemi CF; Miller RJ
    Anesth Prog; 1998; 45(4):150-3. PubMed ID: 10483387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential loss of striatal projection neurons in Huntington disease.
    Reiner A; Albin RL; Anderson KD; D'Amato CJ; Penney JB; Young AB
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5733-7. PubMed ID: 2456581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic options for Huntington's disease.
    Grimbergen YA; Roos RA
    Curr Opin Investig Drugs; 2003 Jan; 4(1):51-4. PubMed ID: 12625029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
    Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
    Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF.
    Cepeda C; Starling AJ; Wu N; Nguyen OK; Uzgil B; Soda T; André VM; Ariano MA; Levine MS
    J Neurosci Res; 2004 Dec; 78(6):855-67. PubMed ID: 15505789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
    Allen KL; Waldvogel HJ; Glass M; Faull RL
    J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Huntington's chorea].
    Benarroch EE
    Medicina (B Aires); 1981; 41(1):114-8. PubMed ID: 6455582
    [No Abstract]   [Full Text] [Related]  

  • 11. Huntington's disease. A decade of progress.
    Shoulson I
    Neurol Clin; 1984 Aug; 2(3):515-26. PubMed ID: 6099868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huntington's disease: genetics, chemical pathology, and management.
    Myers RH; Schoenfeld M; Bird ED
    Prog Med Genet; 1985; 6():91-122. PubMed ID: 2873625
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.